HTR2A and schizophrenia: While the expression of D1−5 (16–18) and 5-HT1A (19), 5-HT2A (20), 5-HT3A (21) receptors has previously been confirmed in PBMCs, few studies have measured the expression of these receptors in PBMCs of schizophrenia patients.